* Say pivotal avelumab study shows positive results in
metastatic merkel cell carcinoma
The post CORRECTED-BRIEF-Merck KGaA, Pfizer present positive mid-stage data on merkel cell carcinoma drug at ASCO appeared first on NASDAQ.
CORRECTED-BRIEF-Merck KGaA, Pfizer present positive mid-stage data on merkel cell carcinoma drug at ASCO
